Skip to main content

Rystiggo Disease Interactions

There is 1 disease interaction with Rystiggo (rozanolixizumab).

Moderate

Rozanolixizumab (applies to Rystiggo) infections

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral

Rozanolixizumab increases the risk of infection and should not be initiated in patients with active infections until treatment has been administered and the infection has resolved. Additionally, vaccination with live-attenuated or live vaccines is not recommended during treatment.

References

  1. (2023) "Product Information. Rystiggo (rozanolixizumab)." UCB Pharma Inc

Rystiggo drug interactions

There are 282 drug interactions with Rystiggo (rozanolixizumab).


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.